G
169.08
6.14 (3.77%)
| Penutupan Terdahulu | 162.94 |
| Buka | 163.16 |
| Jumlah Dagangan | 1,661,458 |
| Purata Dagangan (3B) | 1,956,606 |
| Modal Pasaran | 22,689,888,256 |
| Harga / Jualan (P/S) | 19.38 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2026 |
| Margin Keuntungan | -53.82% |
| Margin Operasi (TTM) | -54.33% |
| EPS Cair (TTM) | -3.39 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 20.80% |
| Nisbah Semasa (MRQ) | 4.11 |
| Aliran Tunai Operasi (OCF TTM) | -272.26 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -67.71 M |
| Pulangan Atas Aset (ROA TTM) | -18.64% |
| Pulangan Atas Ekuiti (ROE TTM) | -4,584.47% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Guardant Health, Inc. | Bercampur | Menaik |
AISkor Stockmoo
-0.6
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -4.0 |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | -0.63 |
|
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 4.53% |
| % Dimiliki oleh Institusi | 97.57% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| AZAR ALEX M II | - | 162.99 | -69 | -11,246 |
| HIDALGO MEDINA MANUEL | - | - | 0 | 0 |
| TARIQ MUSA | - | 158.60 | -116 | -18,398 |
| Jumlah Keseluruhan Kuantiti Bersih | -185 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -29,644 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 160.80 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| HIDALGO MEDINA MANUEL | Pengarah | 17 Oct 2026 | Pelaksanaan pilihan | 232 | - | - |
| TARIQ MUSA | Pengarah | 16 Oct 2026 | Jual (-) | 116 | 158.60 | 18,398 |
| TARIQ MUSA | Pengarah | 15 Oct 2026 | Pelaksanaan pilihan | 250 | - | - |
| AZAR ALEX M II | Pengarah | 14 Oct 2026 | Jual (-) | 69 | 162.99 | 11,246 |
| AZAR ALEX M II | Pengarah | 12 Oct 2026 | Pelaksanaan pilihan | 137 | - | - |
AI Analisis Teknikal
Buka tab Teknikal untuk menjana analisis terkini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |